Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen has malfunctioned, the replacement process is more straightforward than most people expect — but it does not work the way rumours suggest. Device faults do happen, and Eli Lilly has a mechanism for reporting them; your prescriber and pharmacy also need to know. This page explains what counts as a genuine pen malfunction, what to do in the moment, and how a replacement is typically arranged, so you are not left guessing on injection day. Like all Mounjaro treatment, any change to your supply is a prescription matter — a clinician stays in the loop throughout.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding is that a malfunctioned Mounjaro pen works like a faulty household appliance, hand it back, pick up a new one, done. In practice it is more involved than that, and knowing why saves a lot of frustration.
Mounjaro (tirzepatide) is a Prescription-Only Medicine. Each pen is dispensed against a specific prescription, which means a replacement cannot be handed over without a prescriber reviewing the situation first. This is not bureaucracy for its own sake. The prescriber needs to confirm that a genuine device fault occurred, that no dose was received, and that a replacement is clinically appropriate at that moment in your treatment schedule. The full details of how a KwikPen works can help you tell the difference between a fault and a technique issue before you make that call.
There is also a regulatory dimension. The Mounjaro KwikPen is a medical device as well as a medicine, and suspected faults should be reported so that Lilly can investigate batch or mechanism issues. Your pharmacy will usually handle this alongside sorting your replacement, but it means there is a short, formal process rather than an instant counter swap. Recognising this upfront makes the whole thing feel less obstructive.
Not every difficult injection is a device fault. The Mounjaro KwikPen has a specific mechanism: you attach a needle, dial to the correct position, press the injection button and hold it until the dose counter reaches zero. If any part of that sequence fails because of the device (not because of needle attachment or technique) that is where a fault claim becomes legitimate.
Recognised issues include: the plunger not advancing when the button is pressed correctly; the dose window not counting down; the pen locking prematurely before the full dose is delivered; a cracked or visibly damaged cartridge; or the pen arriving with no fluid in the cartridge at all. Needle-related problems, such as a blocked needle tip, are usually a needle fault rather than a pen fault, using the correct replacement needles and changing the needle for each injection prevents most of these. The NHS patient guidance on tirzepatide is a useful reference point for understanding normal device behaviour: NHS tirzepatide medicines information.
If you are unsure whether what happened was a fault, note exactly what occurred (which step failed, what the dose counter showed, whether any resistance was felt) before contacting your pharmacy. That detail speeds up the assessment considerably. You can also find guidance on common pen fault scenarios on our dedicated page, including how the reset button works and when a malfunction means the pen cannot simply be reset.
The process, once you have confirmed something genuinely went wrong, follows a clear sequence. First, stop and do not attempt a second injection or try to restart the pen. If the needle is still attached, cap it carefully and place the whole unit into your sharps bin. Do not try to retrieve any medicine from a faulty pen.
Contact your prescribing pharmacy the same day if possible. At nume, our aftercare team is available seven days a week, reach us through the contact page. You will be asked to describe the fault and confirm your current dose and treatment stage. A GPhC-registered prescriber will review your case; if a replacement is appropriate, a fresh prescription is issued and dispatched. Our pharmacy dispatches treatment from the licensed UK supply chain, so the replacement pen goes through the same route as your original order.
In parallel, the fault should be reported to Eli Lilly's medical information line (the number is in your Patient Information Leaflet) and can also be submitted to the MHRA via the Yellow Card scheme, which covers both medicines and medical devices. This step is worth doing even if it feels like extra admin, it helps identify any wider batch issues.
One practical note on timing: if your missed injection has moved you past your usual injection day, your prescriber will advise whether to inject as soon as the replacement arrives or whether the schedule needs adjusting. The Patient Information Leaflet and your prescriber's guidance take precedence here, do not make that call alone based on what you read online.
If there is a delay of even a day or two while your replacement is arranged, some people find it useful to think through their injection setup more carefully. Most pen malfunctions are genuinely one-off events. A small number trace back to storage conditions, such as a pen that was left outside the fridge for longer than the leaflet allows, or to site preparation. Choosing the right injection site and ensuring the skin is clean and dry reduces the chance of incomplete delivery being mistaken for a device fault.
If you are approaching a repeat prescription and this experience has left you with questions about your ongoing treatment, our prescribers review every repeat order before it is dispensed, there is no auto-renewal. For those who are still working out whether Mounjaro injections are the right route for them, or who want to understand the broader picture of what weight management with tirzepatide involves, our free consultation is the right starting point. A prescriber reviews every submission personally, your questions about device management, injection technique or treatment planning all belong in that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.